Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
In Vivo (Athens, Greece)|April 26, 2017
Rebiopsy of Histological Samples in Pretreated Non-small Cell Lung Cancer: Comparison Among Rebiopsy ProceduresAkito Hata, Nobuyuki Katakami, Shigeki Nanjo, et al.
Oncology Letters|February 22, 2013
Continuous morphine infusion for end-stage lung cancer patientsYoung Hak Kim, Chiyuki Okuda, Yuichi Sakamori, et al.
Biomedical Reports|July 8, 2017
Single nucleotide variant sequencing errors in whole exome sequencing using the Ion Proton SystemShiro Fujita, Katsuhiro Masago, Chiyuki Okuda, et al.
Anticancer Research|May 7, 2017
PD-L1 Expression in Patients with Non-small Cell Lung CancerKatsuhiro Masago, Shiro Fujita, Akito Hata, et al.
Oncology Letters|August 7, 2012
EGFR mutation: Significance as a stratification factor in the era of molecular-targeted therapyYoung Hak Kim, Katsuhiro Masago, Yosuke Togashi, et al.
Japanese Journal of Clinical Oncology|January 19, 2011
Long-term survival in a patient with small-cell lung cancer undergoing hemodialysis who received multiple courses of chemotherapyYosuke Togashi, Young Hak Kim, Katsuhiro Masago, et al.
Cancer Chemotherapy and Pharmacology|September 10, 2015
EGFR-TKI rechallenge with bevacizumab in EGFR-mutant non-small cell lung cancerKyoko Otsuka, Akito Hata, Jumpei Takeshita, et al.
Anticancer Research|December 16, 2014
Clinicopathological factors affecting progression-free survival of patients with previously treated advanced non-small cell lung cancer after S-1 therapy with or without bevacizumabKatsuhiro Masago, Shiro Fujita, Akito Hata, et al.
Medical Oncology (Northwood, London, England)|July 23, 2011
Clinical significance of serum hepatocyte growth factor and epidermal growth factor gene somatic mutations in patients with non-squamous non-small cell lung cancer receiving gefitinib or erlotinibKatsuhiro Masago, Yosuke Togashi, Shiro Fujita, et al.
Oncology|February 1, 2013
Effect of the BCL2 gene polymorphism on survival in advanced-stage non-small cell lung cancer patients who received chemotherapyKatsuhiro Masago, Yosuke Togashi, Shiro Fujita, et al.
Pageof 3